BioPharm International-12-01-2013

BioPharm International

Regulation of Biosimilars: A Matter of Variability, Similarity, and Comparability

December 01, 2013

European Beat

26

12

The European Union is strengthening its pioneering role in the regulation of biosimilars by further developing the basic rules for determining the levels of compatibility for this group of drugs. There are, however, some key issues that are not easy to resolve, as evident in a recent workshop on biosimilars organized by the European Medicines Agency (EMA).

Clinical Trials Head East to Asia

December 01, 2013

Global News

26

12

The rising cost of drug development and the decreasing proportion of drug-naive population in the US and European markets are driving international pharmaceutical companies to consider emerging markets as a location to conduct their clinical trials. Asia stands out among the emerging markets given its double-digit growth rates.

BioPharm International, December 2013 Issue (PDF)

December 01, 2013

Issue PDF

26

12

Click the title above to open the BioPharm International December 2013 issue in an interactive PDF format.